179 related articles for article (PubMed ID: 35372013)
1. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
Loya A; Gombos DS; Patel SP
Front Oncol; 2022; 12():853076. PubMed ID: 35372013
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
Mahjoub H; Loya A; Ayaz T; Weng CY
Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
[TBL] [Abstract][Full Text] [Related]
3. Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.
Choi ME; Jung JM; Kim DH; Won CH; Chang SE; Lee MW; Lee WJ
J Am Acad Dermatol; 2024 May; 90(5):977-985. PubMed ID: 38272394
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancies after ocular adnexal lymphoma diagnosis.
Loya A; Ramachandran V; Ayaz T; Weng CY
BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
7. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry.
Banner L; Joffe D; Lee E; Porcu P; Nikbakht N
Front Med (Lausanne); 2023; 10():1110511. PubMed ID: 37089593
[TBL] [Abstract][Full Text] [Related]
9. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.
Hussain Z; Khan J; Saeed A; Dihowm F
Cancer Diagn Progn; 2021; 1(5):393-398. PubMed ID: 35403153
[TBL] [Abstract][Full Text] [Related]
12. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
14. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
[TBL] [Abstract][Full Text] [Related]
15. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
16. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
17. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
18. Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma.
Nakamura Y; Zhenjie Z; Oya K; Tanaka R; Ishitsuka Y; Okiyama N; Watanabe R; Fujisawa Y
Front Oncol; 2020; 10():524700. PubMed ID: 33392063
[TBL] [Abstract][Full Text] [Related]
19. Survival differences in acral lentiginous melanoma according to socioeconomic status and race.
Yan BY; Barilla S; Strunk A; Garg A
J Am Acad Dermatol; 2022 Feb; 86(2):379-386. PubMed ID: 34363907
[TBL] [Abstract][Full Text] [Related]
20. Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis.
Ozdemir F; Errico MA; Yaman B; Karaarslan I
Dermatol Pract Concept; 2018 Apr; 8(2):140-148. PubMed ID: 29785333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
